hepatocellular carcinoma
Conditions
Interventions
Sponsors
Wangjing Hospital China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: (1) Hepatocellular carcinoma population: patients diagnosed with hepatocellular carcinoma in combination with pathology according to the Western medical diagnostic criteria of the "Standards for the Diagnosis and Treatment of Primary Liver Cancer" (2019 Edition). (2) Liver cancer risk group: According to the "Screening and Surveillance of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection" issued by the expert group of the Hepatocellular Carcinoma Screening and Surveillance Project of the China Foundation for Hepatitis Prevention and Control [46] according to the risk of liver cancer in individuals infected with hepatitis B virus (HBV) according to whether they have liver cirrhosis whether liver function is decompensated whether they are accompanied by obesity diabetes and fatty liver the risk of liver cancer in HBV-infected individuals is comprehensively assessed and the diagnosis is low-risk intermediate-risk Patients with high-risk and very high-risk types. (3) Healthy people: healthy people with normal function of various organs and systems of the body no organic lesions and the results of medical tests such as physical examination and laboratory tests are within the normal range. (4) Age between 18-70 years old male or female; (5) Sign the informed consent form. (6) The patients to be included are newly diagnosed patients who have not yet undergone surgery or other related treatments. Note: Items 1-3 must meet any 1 item and 4-6 must meet all of them to be included
Exclusion criteria
Exclusion criteria: (1) Patients with other primary malignant tumors; (2) Patients with previous diseases of the heart cerebrovascular liver kidney and hematopoietic system. (3) After diagnosis chemotherapy radiotherapy or traditional Chinese medicine treatment; (4) Patients with stained lichen tongue-tie shortening etc. which interfere with the normal collection of tongue image information; (5) The investigator has other circumstances that are not suitable for participating in this study after professional analysis. (Note: Exclusion if any of these circumstances occurs)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete blood count;Tumor markers;tongue mage;Liver function; | — |
Secondary
| Measure | Time frame |
|---|---|
| MRI of abdomen; | — |
Countries
CHINA
Contacts
Public ContactZhang Ming
Wangjing Hospital China Academy of Chinese Medical Sciences
Outcome results
None listed